GURUFOCUS.COM » STOCK LIST » Healthcare » Biotechnology » Shanghai Medicilon Inc (SHSE:688202) » Definitions » EPS (Basic)

Shanghai Medicilon (SHSE:688202) EPS (Basic) : ¥-2.15 (TTM As of Sep. 2024)


View and export this data going back to 2019. Start your Free Trial

What is Shanghai Medicilon EPS (Basic)?

Shanghai Medicilon's basic earnings per share (Basic EPS) for the three months ended in Sep. 2024 was ¥-0.44. Its basic earnings per share (Basic EPS) for the trailing twelve months (TTM) ended in Sep. 2024 was ¥-2.15.

Shanghai Medicilon's EPS (Diluted) for the three months ended in Sep. 2024 was ¥-0.44. Its EPS (Diluted) for the trailing twelve months (TTM) ended in Sep. 2024 was ¥-2.15.

Shanghai Medicilon's EPS without NRI for the three months ended in Sep. 2024 was ¥-0.34. Its EPS without NRIearnings per share without non-recurring items for the trailing twelve months (TTM) ended in Sep. 2024 was -1.78.

During the past 12 months, Shanghai Medicilon's average EPS without NRIGrowth Rate was -212.20% per year. Please click Growth Rate Calculation Example (GuruFocus) to see how GuruFocus calculates Wal-Mart Stores Inc (WMT)'s revenue growth rate. You can apply the same method to get the EPS without NRI Growth Rate using EPS without NRI data.

During the past 10 years, Shanghai Medicilon's highest 3-Year average EPS without NRI Growth Rate was 50.10% per year. The lowest was 10.70% per year. And the median was 31.30% per year.


Shanghai Medicilon EPS (Basic) Historical Data

The historical data trend for Shanghai Medicilon's EPS (Basic) can be seen below:

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.

* Premium members only.

Shanghai Medicilon EPS (Basic) Chart

Shanghai Medicilon Annual Data
Trend Dec14 Dec15 Dec16 Dec17 Dec18 Dec19 Dec20 Dec21 Dec22 Dec23
EPS (Basic)
Get a 7-Day Free Trial Premium Member Only Premium Member Only 0.69 1.07 2.32 2.78 -0.26

Shanghai Medicilon Quarterly Data
Dec19 Mar20 Jun20 Sep20 Dec20 Mar21 Jun21 Sep21 Dec21 Mar22 Jun22 Sep22 Dec22 Mar23 Jun23 Sep23 Dec23 Mar24 Jun24 Sep24
EPS (Basic) Get a 7-Day Free Trial Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only -0.43 -1.19 -0.28 -0.24 -0.44

Shanghai Medicilon EPS (Basic) Calculation

EPS (Basic) is a rough measurement of the amount of a company's profit that can be allocated to one share of its stock. Basic earnings per share (EPS) do not factor in the dilutive effects on convertible securities.

Shanghai Medicilon's Basic EPS for the fiscal year that ended in Dec. 2023 is calculated as

Basic EPS (A: Dec. 2023 )=(Net Income-Preferred Dividends)/Shares Outstanding (Basic Average)
=(-33.211-0)/127.733
=-0.26

Shanghai Medicilon's Basic EPS for the quarter that ended in Sep. 2024 is calculated as

Basic EPS (Q: Sep. 2024 )=(Net Income-Preferred Dividends)/Shares Outstanding (Basic Average)
=(-58.445-0)/131.993
=-0.44

EPS (Basic) for the trailing twelve months (TTM) ended in Sep. 2024 adds up the quarterly data reported by the company within the most recent 12 months, which was ¥-2.15

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.


Shanghai Medicilon  (SHSE:688202) EPS (Basic) Explanation

EPS is the single most important variable used by Wall Street in determining the earnings power of a company. But investors need to be aware that Earnings per Share can be easily manipulated by adjusting depreciation and amortization rate or non-recurring items. That's why GuruFocus lists EPS without NRI, which better reflects the company's underlying performance.


Be Aware

Compared with Earnings per share, a company's cash flow is better indicator of the company's earnings power.

If a company's earnings per share is less than cash flow per share over long term, investors need to be cautious and find out why.


Shanghai Medicilon EPS (Basic) Related Terms

Thank you for viewing the detailed overview of Shanghai Medicilon's EPS (Basic) provided by GuruFocus.com. Please click on the following links to see related term pages.


Shanghai Medicilon Business Description

Traded in Other Exchanges
N/A
Address
Lane 67, Libing Road, Building 5, Pilot Free Trade Zone, Shanghai, CHN, 201299
Shanghai Medicilon Inc is a comprehensive biomedical research and developemnt service company. It provides a full range of one-stop new drug development services for pharmaceutical companies and research institutions around the world in line with domestic and international reporting standards.
Executives
Chen Jin Zhang Director
Chen Guo Xing Director
Lin Zhang Qing Director
Peng Shuang Qing Core technical personnel
Li Zhi Gang Core technical personnel
Xu Yong Mei Core technical personnel
Liu Bin Bin senior management
Zhang Xiao Dong senior management
Xue Chao senior management
Ma Xing Quan senior management
Directors, senior managers, core technical personn
Cai Jin Na Directors, senior managers

Shanghai Medicilon Headlines

No Headlines